These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17911448)

  • 1. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis.
    Uyttenhove C; Sommereyns C; Théate I; Michiels T; Van Snick J
    Ann N Y Acad Sci; 2007 Sep; 1110():330-6. PubMed ID: 17911448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.
    Uyttenhove C; Van Snick J
    Eur J Immunol; 2006 Nov; 36(11):2868-74. PubMed ID: 17048276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection.
    Uyttenhove C; Arendse B; Stroobant V; Brombacher F; Van Snick J
    Eur J Immunol; 2004 Dec; 34(12):3572-81. PubMed ID: 15549728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
    Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
    Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
    Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W
    J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
    Huppert J; Closhen D; Croxford A; White R; Kulig P; Pietrowski E; Bechmann I; Becher B; Luhmann HJ; Waisman A; Kuhlmann CR
    FASEB J; 2010 Apr; 24(4):1023-34. PubMed ID: 19940258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
    Röhn TA; Jennings GT; Hernandez M; Grest P; Beck M; Zou Y; Kopf M; Bachmann MF
    Eur J Immunol; 2006 Nov; 36(11):2857-67. PubMed ID: 17048275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.
    Ishiguro A; Akiyama T; Adachi H; Inoue J; Nakamura Y
    Arthritis Rheum; 2011 Feb; 63(2):455-66. PubMed ID: 20967861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.
    Okiyama N; Sugihara T; Iwakura Y; Yokozeki H; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Aug; 60(8):2505-12. PubMed ID: 19644888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of experimental autoimmune encephalomyelitis by ghrelin.
    Theil MM; Miyake S; Mizuno M; Tomi C; Croxford JL; Hosoda H; Theil J; von Hörsten S; Yokote H; Chiba A; Lin Y; Oki S; Akamizu T; Kangawa K; Yamamura T
    J Immunol; 2009 Aug; 183(4):2859-66. PubMed ID: 19620309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.
    Belmar NA; Lombardo JR; Chao DT; Li O; Ma X; Pong-Afar M; Law DA; Starling GC
    J Neuroimmunol; 2009 Jul; 212(1-2):65-73. PubMed ID: 19477024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.
    Ishigame H; Kakuta S; Nagai T; Kadoki M; Nambu A; Komiyama Y; Fujikado N; Tanahashi Y; Akitsu A; Kotaki H; Sudo K; Nakae S; Sasakawa C; Iwakura Y
    Immunity; 2009 Jan; 30(1):108-19. PubMed ID: 19144317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.
    Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B
    Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.
    Piao WH; Jee YH; Liu RL; Coons SW; Kala M; Collins M; Young DA; Campagnolo DI; Vollmer TL; Bai XF; La Cava A; Shi FD
    Scand J Immunol; 2008 Jan; 67(1):37-46. PubMed ID: 18052963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
    Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
    Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.